Georg-Speyer-Haus

Established in 1904, the Georg-Speyer-Haus stands before you. It has a rich history. It began as a research haven for Paul Ehrlich, its first director. The Georg-Speyer-Haus was specifically created for him as the Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, a private foundation. This building isn’t just bricks and mortar. It represents a legacy of groundbreaking research. The Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, continues this tradition. Today, it delves into the complexities of cancer. The mission is to understand tumor development at a molecular and cellular level. Researchers here strive to discover new and effective cancer therapies. The institute’s focus is sharp. They analyze the interactions of cell types within the tumor environment, the tumor microenvironment. This detailed understanding paves the way for innovative therapeutic strategies. The Georg-Speyer-Haus doesn’t work in isolation. It collaborates closely with institutions like Goethe University Frankfurt. It also works with the University Cancer Center (UCT) and the Frankfurt Cancer Institute (FCI). As a member of the German Consortium for Translational Cancer Research (DKTK), the Georg-Speyer-Haus bridges the gap between research and patient care. It facilitates the transition of discoveries into early clinical trials, bringing hope to those battling cancer. The Georg-Speyer-Haus is supported by the State Ministry of Higher Education, Research and the Arts of the State of Hessen. The Federal Ministry of Health also provides financial backing. This support underscores the institute’s importance in the fight against cancer. The Georg-Speyer-Haus is more than just a research facility. It’s a testament to dedication and innovation in the pursuit of a healthier future.